Lobbyradar DE (Hrsg.). (2026). The role of the Commission was here to facilitate the exchange between Novartis and the HTA Coordination Group Chairs about a medicinal product sent for joint clinical assessment. Abgerufen am 31.07.2026 von https://lbrgst.puca.biz/treffen/27547